Numerous reports have demonstrated that CKS2 expression is often elevated in various cancers, including lymphatic cancer (16), bladder cancer (17), breast cancer (18), cervical cancer (19), nasopharyngeal carcinoma (20), melanocytic carcinoma (21), esophageal squamous cell carcinoma (22), hepatocellular carcinoma (23), and Wilms tumor (24). This evidence concerns the gene CKS2 and cancer.